Cargando…
Inhibition of angiogenesis in endothelial cells by Human Lysyl oxidase propeptide
Angiogenesis is a critical process involved in normal physiology. Pathological angiogenesis is observed in vascular diseases and neoplasia. The propeptide domain of LOX (LOX-PP) has been shown to inhibit tumorigenesis in various cancers. In this study, we explored the role of both overexpressed and...
Autores principales: | Nareshkumar, Ragavachetty Nagaraj, Sulochana, Konerirajapuram Natarajan, Coral, Karunakaran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6041307/ https://www.ncbi.nlm.nih.gov/pubmed/29993014 http://dx.doi.org/10.1038/s41598-018-28745-8 |
Ejemplares similares
-
A molecular model of human Lysyl Oxidase (LOX) with optimal copper orientation in the catalytic cavity for induced fit docking studies with potential modulators
por: Bhuvanasundar, Renganathan, et al.
Publicado: (2014) -
Insights into the structure and dynamics of lysyl oxidase propeptide, a flexible protein with numerous partners
por: Vallet, Sylvain D., et al.
Publicado: (2018) -
Lysyl oxidase secreted by tumour endothelial cells promotes angiogenesis and metastasis
por: Osawa, T, et al.
Publicado: (2013) -
CTR1 Silencing Inhibits Angiogenesis by Limiting Copper Entry into Endothelial Cells
por: Narayanan, Gomathy, et al.
Publicado: (2013) -
Blimp1 Activation by AP-1 in Human Lung Cancer Cells Promotes a Migratory Phenotype and Is Inhibited by the Lysyl Oxidase Propeptide
por: Yu, Ziyang, et al.
Publicado: (2012)